ADPT Adaptive Biotechnologies Corporation

NASDAQ
$28.05

Adaptive Biotechnologies Corporation (ADPT) Earnings News

Earnings press releases, previews and reviews for Adaptive Biotechnologies Corporation (ADPT), newest first. Our most recent is review: Adaptive Biotechnologies Reaches Profitability Early as MRD Momentum Overshadows a Genentech-Distorted Revenue Decline.